Latest Conference Articles

Poster highlights from the the 59th Annual Scientific Session of the American College of Cardiology.

An NCCN panel reviewed changes to the NCCN Breast Cancer Guidelines for invasive breast cancer.

Specialty pharmacies are meant to address gaps in care provided by community pharmacy practices.

For some time, medical science has recognized that the human papilloma virus (HPV) causes nearly all cases of cervical cancer.

Ted Eytan, MD, and Holly Potter, discussed the power of health IT and social media to improve the quality of healthcare.

Consider this a call to action. Telemedicine needs more attention in neurology practices and hospitals

Kathryn Kern-Stout, MD, MBA, discussed some of the challenges her institution had to overcome during the EHR selection and implementation process.

Allison Connelly-Flores, Urban Health Care, Inc, told her story about despair, faith, hope, frustration, jubilation, and, through all of these things, success.

Many physicians have already taken the step to implement an EHR, and some have not failed at it... yet, anyway.

One of the ongoing sessions is the panelist of healthcare bloggers, and each day presents a different panel of recognizable voices.

Mrunal Shah, MD, ABFM, discussed his large integrated health system's experiences with implementing a system-wide electronic record.

Couldn't make it to HIMSS? No problem, we've got you covered. Check back for the latest Web exclusives on HIMSS10 sessions.

EMRs have the ability to transform healthcare and give providers the ability to streamline workflow and spend more time with patients.

Follow live Twitter updates from the American College of Cardiology 2010 meeting.

The likelihood of patients "doctor shopping" jumps when they are simultaneously prescribed a single additional class of a controlled substance.

Physicians should ensure that they have a support system in place when dealing with malpractice litigation.

Your overall goal is to stop a case before it's filed, but in the event that a suit is brought doctors most often settle.

Four experts discuss what they believe is in store for pain medicine in the coming years.

A study of a three-week treatment program for chronic pain revealed African Americans experienced worse outcomes compared to a matched group of Caucasians.

Roundup: Analgesic efficacy of Milnacipran; tolerability of Tapentadol; efficacy/safety of Tapentadol; epidural steroid injection; outcomes in osteoarthritis.

Roundup: PAIN BLITZ pilot project; dose stability of Tapentadol ER; failed back surgery syndrome; sympathetic nerve block; combined radiofrequency ablation.

Roundup: Neuropathic cancer pain; spinal/peripheral neuromodulation; comorbid depressive disorder; morphine and prialt IT therapies; spinal cord stimulation.

A lively question and answer session follows a pro and con debate on the use of opioids.

A study of the costs of targeted medicine delivery systems, and an analysis of the differences between the costs of treatment for chronic pain treatments.

A study of minimally invasive facet arthrodesis and spinal cord stimulation show they can achieve relief for patients with back pain.

Roundup: Safety and efficacy of Diclofenac; effect of Duloxetine; MIS non-instrumented facet arthodesis; paresthesia coverage; and Milnacipran for fibromyalgia.

A frank discussion of healthcare reform and its expected effects on the practice of pain medicine.

A debate over whether the use of prescription opioids is really the most effective method of pain control.

A 10-year study showed that whle methadone represented less than 5% of all opioid prescriptions, it was responsible for a third of the deaths.

Doctors showed positive results of peripheral nerve stimulation in a patient suffering from pain after a herpes breakout.